Image 1
Kariva Kit
Product Images NDC 0555-9050
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Kariva (NDC 0555-9050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 10
This is a medication package for 6 Cyclic Tablet Dispensers x 28 Tablets of Karivae, which is a combination of desogestrel/ethinyl estradiol and ethinyl estradiol tablets USP used for women's health. The usual dosage is one tablet daily as directed. The package contains foil pouches containing blister cards and "Briel Summary and Detailed Patient Labeling Inserts" for each prescription, as well as a vinyl wallet. It should be stored at 20° to 25°C (68" to 77°F) and kept out of the reach of children. Full prescribing information can be found in the enclosed package insert.*
Image 2
Image 3
Image 4
This appears to be a list of studies and their respective dates concerning women's contraceptive use. The studies include NICHD Women's Contraceptive Study in 2002 (ever and current use), French E3N cohort Study in 2005 (ever use), Shanghai Women's Health Study in 2009 (ever use), The Nurses' Health Study Il in 2010 (ever and current use), and Oxford Family Planning Association Study in 2013 (ever use). The Danish Sex Hormone Register Study from 2017 is also mentioned. There are some effect estimate ranges included in the text as well.*
Image 5
Image 6
Image 7
Image 8
Image 9
This is a description of a contraceptive product called Karwae. It comes in 6 cyclic tablet dispensers and each dispenser contains 28 tablets. Each tablet is a combination of desogestrel/ethinyl estradiol and ethinyl estradiol tablets USP with a composition of 0.15 mg/0.02 mg and 0.01 mg. It is to be used to prevent pregnancy, but does not protect against HIV infection (AIDS) or other sexually transmitted diseases.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
